Go Pro

LMF Acquisition Opportunities (LMAOW) Financials

$0.03 0.00 (0.00%)
As of 07/17/2026
Annual Income Statements for LMF Acquisition Opportunities

Annual Income Statements for LMF Acquisition Opportunities

This table shows LMF Acquisition Opportunities' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-4.60 -11 -26 -25 -12
Consolidated Net Income / (Loss)
-4.60 -12 -26 -25 -12
Net Income / (Loss) Continuing Operations
-4.60 -11 -26 -25 -12
Total Pre-Tax Income
-4.60 -12 -26 -25 -12
Total Operating Income
-4.45 -12 -14 -18 -12
Total Gross Profit
0.00 0.00 0.00 0.14 1.18
Total Revenue
0.00 0.00 0.00 0.14 1.23
Operating Revenue
- - 0.00 0.14 1.23
Total Cost of Revenue
0.00 0.00 0.00 0.00 0.05
Operating Cost of Revenue
- - 0.00 0.00 0.05
Total Operating Expenses
4.45 12 14 18 13
Selling, General & Admin Expense
1.68 6.92 8.24 8.87 5.84
Research & Development Expense
2.77 2.50 5.97 9.11 7.52
Total Other Income / (Expense), net
-0.15 0.62 -12 -6.99 0.03
Interest Expense
0.21 0.63 6.03 0.24 0.03
Interest & Investment Income
- - 0.00 0.10 0.33
Other Income / (Expense), net
0.06 1.25 -5.99 -6.84 -0.27
Income Tax Expense
-0.00 0.00 0.00 0.00 0.00
Basic Earnings per Share
($0.63) ($1.48) ($30.26) ($66.33) ($5.86)
Weighted Average Basic Shares Outstanding
7.24M 8.21M 866.81K 374.36K 2.07M
Weighted Average Diluted Shares Outstanding
7.24M 8.21M 866.81K 8.72M 3.99M
Weighted Average Basic & Diluted Shares Outstanding
0.00 13.30M - 8.72M 3.99M

Quarterly Income Statements for LMF Acquisition Opportunities

This table shows LMF Acquisition Opportunities' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-7.23 -9.46 -13 -3.24 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Consolidated Net Income / (Loss)
-7.23 -9.46 -13 -3.24 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Net Income / (Loss) Continuing Operations
-7.23 -9.46 -13 -3.24 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Total Pre-Tax Income
-7.23 -9.46 -13 -3.23 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Total Operating Income
-2.94 -2.94 -3.95 -4.67 -4.46 -4.77 -3.82 -1.76 -3.58 -3.02 -3.60
Total Gross Profit
0.00 - 0.00 0.00 0.07 0.07 0.29 0.31 0.17 0.41 0.45
Total Revenue
0.00 - 0.00 0.00 0.07 0.07 0.29 0.34 0.18 0.42 0.50
Operating Revenue
0.00 - 0.00 0.00 0.07 0.07 0.29 0.34 0.18 0.42 0.50
Total Cost of Revenue
0.00 - 0.00 0.00 0.00 - 0.00 0.03 0.01 0.01 0.05
Operating Cost of Revenue
0.00 - 0.00 0.00 0.00 - 0.00 0.03 0.01 0.01 0.05
Total Operating Expenses
2.94 2.94 3.95 4.67 4.52 4.83 4.12 2.07 3.75 3.43 4.05
Selling, General & Admin Expense
1.86 1.76 2.25 2.34 2.19 2.10 1.68 1.03 1.90 1.23 1.71
Research & Development Expense
1.09 1.18 1.70 2.33 2.34 2.74 2.43 1.04 1.85 2.20 2.34
Total Other Income / (Expense), net
-4.29 -6.53 -8.75 1.44 -0.02 0.35 0.05 -0.25 0.11 0.11 0.09
Interest Expense
5.17 0.20 0.14 0.08 0.27 -0.25 0.01 0.01 0.00 0.01 0.01
Interest & Investment Income
0.00 - 0.00 0.03 0.06 0.02 0.05 0.05 0.11 0.13 0.09
Other Income / (Expense), net
0.88 -6.33 -8.60 1.49 0.19 0.08 0.02 -0.28 0.00 - 0.00
Income Tax Expense
0.00 -0.01 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00
Basic Earnings per Share
($9.02) ($10.91) ($4.73) ($1.03) ($1.10) ($11.80) ($4.38) ($0.18) ($0.13) ($1.40) ($0.90)
Weighted Average Basic Shares Outstanding
801.94K 866.81K 2.68M 3.15M 4.09M 374.36K 861.79K 11.33M 26.39M 2.07M 3.92M
Weighted Average Diluted Shares Outstanding
801.94K 866.81K 2.68M 3.15M 4.46M 8.72M 10.56M 11.33M 36.05M 3.99M 4.00M
Weighted Average Basic & Diluted Shares Outstanding
36.98M 0.00 75.42M 4.17M 4.46M 8.72M 10.56M 27.91M 36.05M 3.99M 4.00M

Annual Cash Flow Statements for LMF Acquisition Opportunities

This table details how cash moves in and out of LMF Acquisition Opportunities' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-2.30 -0.46 0.13 1.64 10
Net Cash From Operating Activities
-5.11 -7.79 -10 -16 -14
Net Cash From Continuing Operating Activities
-5.11 -7.79 -10 -16 -14
Net Income / (Loss) Continuing Operations
-4.60 -12 -26 -25 -12
Consolidated Net Income / (Loss)
-4.60 -12 -26 -25 -12
Amortization Expense
0.14 0.24 0.05 0.10 0.02
Non-Cash Adjustments To Reconcile Net Income
0.02 1.60 13 7.73 0.89
Changes in Operating Assets and Liabilities, net
-0.68 2.55 2.88 0.99 -2.36
Net Cash From Investing Activities
0.00 0.00 0.00 0.00 0.00
Net Cash From Continuing Investing Activities
0.00 0.00 0.00 0.00 0.00
Net Cash From Financing Activities
2.82 7.33 10 18 24
Net Cash From Continuing Financing Activities
2.82 7.33 10 18 24
Repayment of Debt
-0.02 -0.06 -0.40 -6.10 -0.83
Issuance of Debt
2.75 3.56 8.80 1.69 0.77
Issuance of Common Equity
- 0.00 4.74 21 22
Other Financing Activities, net
0.09 3.84 -2.73 0.85 1.82
Cash Interest Paid
0.00 0.01 1.13 0.55 0.00
Cash Income Taxes Paid
0.00 0.00 0.00 0.00 0.00

Quarterly Cash Flow Statements for LMF Acquisition Opportunities

This table details how cash moves in and out of LMF Acquisition Opportunities' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
0.06 0.10 4.84 -3.84 0.90 -0.26 3.48 1.01 7.46 -1.78 -2.63
Net Cash From Operating Activities
-1.34 -4.49 -3.49 -2.82 -5.00 -4.69 -2.65 -3.01 -3.84 -4.09 -2.76
Net Cash From Continuing Operating Activities
-1.34 -4.49 -3.49 -2.82 -5.00 -4.69 -2.65 -3.01 -3.84 -4.09 -2.76
Net Income / (Loss) Continuing Operations
-7.23 -9.46 -13 -3.24 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Consolidated Net Income / (Loss)
-7.23 -9.46 -13 -3.24 -4.48 -4.42 -3.77 -2.00 -3.47 -2.90 -3.52
Amortization Expense
0.01 0.01 0.03 0.03 0.05 - 0.01 0.01 - - 0.01
Non-Cash Adjustments To Reconcile Net Income
4.70 6.71 9.04 -1.45 0.01 0.14 0.15 0.38 0.29 0.07 0.09
Changes in Operating Assets and Liabilities, net
1.18 -1.75 0.14 1.83 -0.58 -0.41 0.96 -1.39 -0.66 -1.26 0.66
Net Cash From Investing Activities
- - 0.00 - - - 0.00 - - - 0.00
Net Cash From Continuing Investing Activities
- - 0.00 - - - 0.00 - - - 0.00
Net Cash From Financing Activities
1.40 4.59 8.33 -1.02 5.91 4.43 6.13 4.01 11 2.31 0.13
Net Cash From Continuing Financing Activities
1.40 4.59 8.33 -1.02 5.91 4.43 6.13 4.01 11 2.31 0.13
Repayment of Debt
-0.22 3.03 -1.81 -0.96 -3.19 -0.14 -0.22 -0.37 - -0.24 -0.20
Issuance of Common Equity
0.12 3.46 4.54 -0.05 13 3.86 6.35 3.59 15 1.79 0.33
Other Financing Activities, net
- -4.10 4.62 -0.00 -3.77 - 0.00 0.80 -3.76 -0.00 0.00
Cash Interest Paid
0.20 0.42 - - 0.08 0.03 0.00 - - - 0.00

Annual Balance Sheets for LMF Acquisition Opportunities

This table presents LMF Acquisition Opportunities' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
0.27 0.60 3.04 3.51 4.66 14
Total Current Assets
0.04 0.60 1.52 2.31 3.77 14
Cash & Equivalents
0.04 0.51 0.05 0.18 1.82 12
Accounts Receivable
- 0.06 0.01 0.00 0.11 0.24
Inventories, net
- - - - 0.00 0.07
Prepaid Expenses
0.00 0.03 1.46 2.13 1.84 1.30
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.23 0.00 1.52 1.21 0.89 0.58
Other Noncurrent Operating Assets
0.23 0.00 1.52 1.21 0.89 0.58
Total Liabilities & Shareholders' Equity
0.27 0.60 3.04 3.51 4.66 14
Total Liabilities
0.25 3.42 24 17 6.84 3.74
Total Current Liabilities
0.25 3.12 16 13 6.84 3.74
Short-Term Debt
0.13 2.38 1.18 4.74 0.57 0.53
Accounts Payable
0.12 0.09 1.93 4.37 3.05 0.95
Accrued Expenses
- 0.19 2.25 1.52 3.19 2.27
Other Current Liabilities
- 0.47 11 2.31 0.03 0.00
Total Noncurrent Liabilities
0.00 0.30 7.65 4.34 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.02 -2.82 -21 -14 -2.18 10
Total Preferred & Common Equity
0.02 -2.82 -21 -14 -2.18 10
Preferred Stock
0.00 - 0.00 0.00 0.00 0.00
Total Common Equity
0.02 -2.82 -21 -14 -2.18 10
Common Stock
0.03 73 68 101 137 162
Retained Earnings
-0.01 -76 -89 -115 -140 -152

Quarterly Balance Sheets for LMF Acquisition Opportunities

This table presents LMF Acquisition Opportunities' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
2.25 7.74 3.47 4.59 7.60 8.38 16 11
Total Current Assets
2.25 6.54 2.41 3.62 6.78 7.65 15 11
Cash & Equivalents
0.07 5.02 1.18 2.08 5.30 6.30 14 9.35
Accounts Receivable
0.00 - - 0.07 0.11 0.22 0.22 0.18
Inventories, net
- - - - 0.04 0.08 0.08 0.06
Prepaid Expenses
2.17 1.52 1.24 1.47 1.33 1.05 0.81 1.18
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
0.00 1.20 1.05 0.97 0.81 0.74 0.66 0.50
Other Noncurrent Operating Assets
0.00 1.20 1.05 0.97 0.81 0.74 0.66 0.50
Total Liabilities & Shareholders' Equity
2.25 7.74 3.47 4.59 7.60 8.38 16 11
Total Liabilities
18 12 10 6.64 7.03 5.04 4.07 3.95
Total Current Liabilities
12 9.65 9.93 6.64 7.03 5.04 4.07 3.95
Short-Term Debt
4.41 1.49 3.14 0.00 0.36 0.00 0.00 0.33
Accounts Payable
5.04 3.88 4.12 3.69 3.40 3.16 2.02 0.72
Accrued Expenses
1.48 1.54 2.26 2.29 3.26 1.88 2.05 2.90
Other Current Liabilities
1.50 2.73 0.30 0.11 0.02 0.00 0.00 0.00
Total Noncurrent Liabilities
5.72 2.57 0.44 0.00 0.00 0.00 0.00 0.00
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-16 -4.47 -6.90 -2.05 0.57 3.34 11 7.32
Total Preferred & Common Equity
-16 -4.47 -6.90 -2.05 0.57 3.34 11 7.32
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
-16 -4.47 -6.90 -2.05 0.57 3.34 11 7.32
Common Stock
100 123 124 133 144 149 160 163
Retained Earnings
-116 -127 -131 -135 -143 -145 -149 -155

Annual Metrics And Ratios for LMF Acquisition Opportunities

This table displays calculated financial ratios and metrics derived from LMF Acquisition Opportunities' official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
13,041,000.00 12,699,668.00 36,979,724.00 4,463,148.00 36,047,134.00
DEI Adjusted Shares Outstanding
52,164.00 50,799.00 147,919.00 446,315.00 3,604,713.00
DEI Earnings Per Adjusted Shares Outstanding
-88.11 -216.26 -177.34 -55.63 -3.37
Growth Metrics
- - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 814.07%
EBITDA Growth
0.00% -138.23% -99.29% -21.97% 49.46%
EBIT Growth
0.00% -136.15% -95.09% -22.19% 49.60%
NOPAT Growth
0.00% -160.94% -22.41% -25.56% 31.76%
Net Income Growth
0.00% -165.23% -115.19% 5.34% 51.07%
EPS Growth
0.00% -134.92% -115.19% 0.00% 0.00%
Operating Cash Flow Growth
0.00% -52.41% -31.96% -55.63% 15.04%
Free Cash Flow Firm Growth
0.00% 0.00% -649.66% 17.30% 22.21%
Invested Capital Growth
0.00% -1,461.80% 58.55% 30.96% 69.69%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 98.53% 40.07%
EBITDA Q/Q Growth
0.00% -32.12% -12.37% 15.65% 11.86%
EBIT Q/Q Growth
0.00% -35.28% -12.36% 15.63% 11.85%
NOPAT Q/Q Growth
0.00% -52.85% 25.17% -11.43% 12.56%
Net Income Q/Q Growth
0.00% -45.92% -4.23% 16.87% 11.09%
EPS Q/Q Growth
0.00% -28.70% -4.23% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% -7.75% 7.36% -1.32% 4.22%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% -1.84% -8.53% 5.79%
Invested Capital Q/Q Growth
0.00% -30.04% 15.11% 17.08% 54.81%
Profitability Metrics
- - - - -
Gross Margin
0.00% 0.00% 0.00% 100.00% 95.71%
EBITDA Margin
0.00% 0.00% 0.00% -18,208.89% -1,006.73%
Operating Margin
0.00% 0.00% 0.00% -13,216.30% -986.63%
EBIT Margin
0.00% 0.00% 0.00% -18,284.44% -1,008.18%
Profit (Net Income) Margin
0.00% 0.00% 0.00% -18,392.59% -984.60%
Tax Burden Percent
99.98% 100.01% 100.00% 100.01% 100.02%
Interest Burden Percent
104.83% 117.71% 129.85% 100.58% 97.64%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
328.73% 103.40% 151.49% 309.35% -295.15%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% -604.19% -132.24%
Return on Assets (ROA)
0.00% 0.00% 0.00% -607.76% -129.15%
Return on Common Equity (ROCE)
328.73% 103.40% 151.49% 309.35% -295.15%
Return on Equity Simple (ROE_SIMPLE)
163.21% 58.71% 189.13% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-3.11 -8.13 -9.95 -12 -8.52
NOPAT Margin
0.00% 0.00% 0.00% -9,251.41% -690.64%
Net Nonoperating Expense Percent (NNEP)
72.31% 75.03% 184.14% 322.21% -57.13%
Return On Investment Capital (ROIC_SIMPLE)
- - 207.71% 776.22% -77.90%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 4.30%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 6,571.85% 473.10%
R&D to Revenue
0.00% 0.00% 0.00% 6,744.44% 609.24%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 13,316.30% 1,082.33%
Earnings before Interest and Taxes (EBIT)
-4.39 -10 -20 -25 -12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.25 -10 -20 -25 -12
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.83
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.83
Price to Revenue (P/Rev)
0.00 0.00 0.00 64.14 7.01
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 54.91 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 19.72 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
-0.91 -0.43 -0.65 -0.26 0.05
Long-Term Debt to Equity
-0.06 -0.37 -0.31 0.00 0.00
Financial Leverage
-0.73 -0.46 -0.51 -0.48 -1.54
Leverage Ratio
-0.31 -0.15 -0.19 -0.51 2.29
Compound Leverage Factor
-0.33 -0.18 -0.25 -0.51 2.23
Debt to Total Capital
-995.72% -74.00% -189.62% -35.67% 4.80%
Short-Term Debt to Total Capital
-925.29% -9.87% -99.06% -35.67% 4.80%
Long-Term Debt to Total Capital
-70.43% -64.13% -90.56% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
1,095.72% 174.00% 289.62% 135.67% 95.20%
Debt to EBITDA
-0.60 -0.87 -0.45 -0.02 -0.04
Net Debt to EBITDA
-0.48 -0.87 -0.44 0.05 0.92
Long-Term Debt to EBITDA
-0.04 -0.76 -0.22 0.00 0.00
Debt to NOPAT
-0.82 -1.09 -0.91 -0.05 -0.06
Net Debt to NOPAT
-0.66 -1.08 -0.90 0.10 1.34
Long-Term Debt to NOPAT
-0.06 -0.94 -0.44 0.00 0.00
Altman Z-Score
-183.21 -56.50 -67.80 -59.44 -15.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - -
Current Ratio
0.19 0.09 0.18 0.55 3.63
Quick Ratio
0.18 0.00 0.01 0.28 3.26
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 3.09 -17 -14 -11
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 4.90 -2.81 -57.49 -351.98
Operating Cash Flow to Interest Expense
-24.12 -12.37 -1.71 -65.60 -438.68
Operating Cash Flow Less CapEx to Interest Expense
-24.12 -12.37 -1.71 -65.60 -438.68
Efficiency Ratios
- - - - -
Asset Turnover
0.00 0.00 0.00 0.03 0.13
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 7.07
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.03
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 51.61
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 13,752.92
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 -13,701.31
Capital & Investment Metrics
- - - - -
Invested Capital
-0.77 -12 -4.97 -3.43 -1.04
Invested Capital Turnover
0.00 0.00 0.00 -0.03 -0.55
Increase / (Decrease) in Invested Capital
0.00 -11 7.01 1.54 2.39
Enterprise Value (EV)
133 61 25 7.41 -2.80
Market Capitalization
131 52 16 8.66 8.65
Book Value per Share
($0.22) ($1.63) ($0.38) ($0.49) $0.29
Tangible Book Value per Share
($0.22) ($1.63) ($0.38) ($0.49) $0.29
Total Capital
-0.26 -12 -4.79 -1.61 11
Total Debt
2.56 8.83 9.08 0.57 0.53
Total Long-Term Debt
0.18 7.65 4.34 0.00 0.00
Net Debt
2.05 8.78 8.91 -1.25 -11
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-0.65 -13 -6.17 -4.32 -1.62
Debt-free Net Working Capital (DFNWC)
-0.14 -13 -5.99 -2.50 10
Net Working Capital (NWC)
-2.52 -15 -11 -3.08 9.84
Net Nonoperating Expense (NNE)
1.48 4.06 16 12 3.63
Net Nonoperating Obligations (NNO)
2.05 8.78 8.91 -1.25 -11
Total Depreciation and Amortization (D&A)
0.14 0.24 0.05 0.10 0.02
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -3,200.00% -131.04%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% -1,852.59% 839.79%
Net Working Capital to Revenue
0.00% 0.00% 0.00% -2,277.78% 797.24%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($70.00) ($30.25) ($66.30) ($5.86)
Adjusted Weighted Average Basic Shares Outstanding
1.04M 328.45K 866.81K 374.36K 2.07M
Adjusted Diluted Earnings per Share
$0.00 ($70.00) ($30.25) ($66.30) $0.00
Adjusted Weighted Average Diluted Shares Outstanding
1.04M 328.45K 866.81K 374.36K 3.99M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
386.06K 531.86K 0.00 872.10K 3.99M
Normalized Net Operating Profit after Tax (NOPAT)
-3.11 -8.13 -9.95 -12 -8.52
Normalized NOPAT Margin
0.00% 0.00% 0.00% -9,251.41% -690.64%
Pre Tax Income Margin
0.00% 0.00% 0.00% -18,390.37% -984.36%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
-20.68 -16.44 -3.35 -101.16 -401.32
NOPAT to Interest Expense
-14.69 -12.90 -1.65 -51.19 -274.92
EBIT Less CapEx to Interest Expense
-20.68 -16.44 -3.35 -101.16 -401.32
NOPAT Less CapEx to Interest Expense
-14.69 -12.90 -1.65 -51.19 -274.92
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for LMF Acquisition Opportunities

This table displays calculated financial ratios and metrics derived from LMF Acquisition Opportunities' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
18,570,971.00 36,979,724.00 75,419,458.00 75,419,458.00 4,168,972.00 4,463,148.00 8,721,036.00 10,563,748.00 27,914,596.00 36,047,134.00 3,993,719.00
DEI Adjusted Shares Outstanding
74,284.00 147,919.00 301,678.00 301,678.00 416,897.00 446,315.00 872,104.00 1,056,375.00 2,791,460.00 3,604,713.00 3,993,719.00
DEI Earnings Per Adjusted Shares Outstanding
-97.36 -63.93 -42.09 -10.73 -10.74 -9.90 -4.33 -1.90 -1.24 -0.81 -0.88
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 169.12% 526.87% 68.94%
EBITDA Growth
-17.39% -31.55% -88.12% -43.13% -106.31% 49.31% 69.71% 35.44% 15.17% 35.65% 5.22%
EBIT Growth
-16.46% -31.56% -88.41% -43.26% -107.09% 49.37% 69.68% 35.83% 16.06% 35.65% 5.33%
NOPAT Growth
-66.31% 61.94% 13.77% -24.51% -51.46% -62.31% 3.24% 62.39% 19.68% 36.69% 5.73%
Net Income Growth
-282.24% -12.69% -78.93% -32.24% 38.08% 53.27% 70.29% 38.13% 22.47% 34.28% 6.65%
EPS Growth
-282.24% -12.69% -78.93% 74.88% 0.00% 53.27% 0.00% 82.52% 0.00% 34.28% 0.00%
Operating Cash Flow Growth
-46.28% 15.41% -52.05% -30.20% -274.12% -4.64% 23.91% -6.48% 23.15% 12.76% -4.03%
Free Cash Flow Firm Growth
-105.28% -256.09% 95.86% 74.42% 10.85% 46.26% -1,103.34% -94.17% 10.22% 7.64% -38.63%
Invested Capital Growth
36.51% 58.55% -82.32% -48.62% 29.32% 30.96% 19.63% 40.06% 44.39% 69.69% 61.03%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% -1.47% 337.31% 15.36% -45.86% 129.51% 17.86%
EBITDA Q/Q Growth
6.96% -352.42% -35.40% 74.89% -34.11% -11.16% 19.08% 46.48% -76.22% 15.67% -19.18%
EBIT Q/Q Growth
7.13% -349.88% -35.53% 74.70% -34.26% -9.99% 18.85% 46.45% -75.61% 15.67% -19.38%
NOPAT Q/Q Growth
21.55% 0.17% -34.49% -18.20% 4.56% -6.98% 19.82% 54.06% -103.82% 15.67% -19.38%
Net Income Q/Q Growth
-195.55% -30.77% -34.26% 74.51% -38.38% 1.32% 14.64% 46.92% -73.43% 16.36% -21.25%
EPS Q/Q Growth
-195.55% -30.77% -34.26% 78.22% 0.00% 0.00% 0.00% 59.09% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
38.36% -235.45% 22.23% 19.04% -77.12% 6.18% 43.45% -13.30% -27.84% -6.50% 32.56%
Free Cash Flow Firm Q/Q Growth
16.05% -67.26% 96.57% -431.29% -192.57% -0.82% 23.22% 14.27% -35.29% -3.72% -15.25%
Invested Capital Q/Q Growth
-75.96% 15.11% -9.47% 9.11% 16.32% 17.08% -27.42% 32.21% 22.36% 54.81% -63.81%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
0.00% 0.00% 0.00% 0.00% 100.00% 100.00% 100.00% 92.01% 92.35% 97.14% 90.71%
EBITDA Margin
0.00% 0.00% 0.00% 0.00% -6,204.41% -7,000.00% -1,295.22% -600.89% -1,955.74% -718.57% -726.67%
Operating Margin
0.00% 0.00% 0.00% 0.00% -6,552.94% -7,114.93% -1,304.44% -519.53% -1,955.74% -718.57% -727.88%
EBIT Margin
0.00% 0.00% 0.00% 0.00% -6,270.59% -7,000.00% -1,298.98% -602.96% -1,955.74% -718.57% -727.88%
Profit (Net Income) Margin
0.00% 0.00% 0.00% 0.00% -6,585.29% -6,595.52% -1,287.37% -592.31% -1,897.27% -691.43% -711.31%
Tax Burden Percent
100.00% 99.95% 100.00% 100.09% 100.00% 100.00% 100.08% 100.00% 100.00% 100.00% 100.09%
Interest Burden Percent
351.24% 102.15% 101.14% 101.79% 105.02% 94.22% 99.03% 98.23% 97.01% 96.22% 97.64%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-61.35% 151.49% 414.57% 355.57% 332.70% 309.35% 813.97% 824.21% -290.37% -295.15% -302.01%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 0.00% -124.81% -231.31% -72.50% -77.95% -171.31% -94.25% -110.84%
Return on Assets (ROA)
0.00% 0.00% 0.00% 0.00% -131.07% -217.94% -71.85% -76.58% -166.19% -90.69% -108.32%
Return on Common Equity (ROCE)
18.54% 151.49% 414.57% 355.57% 332.70% 309.35% 813.97% 824.21% -290.37% -295.15% -302.01%
Return on Equity Simple (ROE_SIMPLE)
158.25% 0.00% 711.67% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-2.06 -2.06 -2.77 -3.27 -3.12 -3.34 -2.68 -1.23 -2.51 -2.11 -2.52
NOPAT Margin
0.00% 0.00% 0.00% 0.00% -4,587.06% -4,980.45% -913.11% -363.67% -1,369.02% -503.00% -509.52%
Net Nonoperating Expense Percent (NNEP)
-10.65% 83.69% 286.18% -0.64% 34.09% 28.25% -37.20% -35.60% -12.20% -12.46% -14.32%
Return On Investment Capital (ROIC_SIMPLE)
- 42.93% 664.66% 86.90% 152.01% 207.39% -288.30% -36.79% -21.85% -19.31% -32.99%
Cost of Revenue to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.99% 7.65% 2.86% 9.29%
SG&A Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 3,217.65% 3,128.36% 574.74% 304.73% 1,037.16% 291.90% 345.05%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 3,435.29% 4,086.57% 829.69% 306.80% 1,010.93% 523.81% 473.54%
Operating Expenses to Revenue
0.00% 0.00% 0.00% 0.00% 6,652.94% 7,214.93% 1,404.44% 611.54% 2,048.09% 815.71% 818.59%
Earnings before Interest and Taxes (EBIT)
-2.06 -9.26 -13 -3.18 -4.26 -4.69 -3.81 -2.04 -3.58 -3.02 -3.60
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-2.05 -9.25 -13 -3.15 -4.22 -4.69 -3.80 -2.03 -3.58 -3.02 -3.60
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.00 0.00 0.00 25.62 1.35 1.39 0.83 2.03
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 25.62 1.35 1.39 0.83 2.03
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.00 261.17 64.14 33.82 5.87 18.06 7.01 10.35
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 0.00 230.56 54.91 22.30 0.00 2.44 0.00 4.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
-0.64 -0.65 -0.91 -0.46 0.00 -0.26 0.64 0.00 0.00 0.05 0.05
Long-Term Debt to Equity
-0.36 -0.31 -0.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-1.18 -0.51 -0.45 -0.55 -0.44 -0.48 1.51 1.22 -1.68 -1.54 -1.77
Leverage Ratio
1.34 -0.19 -0.72 -0.32 -0.38 -0.51 -3.92 -3.33 2.14 2.29 2.39
Compound Leverage Factor
4.69 -0.19 -0.73 -0.32 -0.40 -0.48 -3.89 -3.27 2.07 2.20 2.34
Debt to Total Capital
-175.33% -189.62% -975.24% -83.49% 0.00% -35.67% 39.12% 0.00% 0.00% 4.80% 4.33%
Short-Term Debt to Total Capital
-76.26% -99.06% -358.65% -83.49% 0.00% -35.67% 39.12% 0.00% 0.00% 4.80% 4.33%
Long-Term Debt to Total Capital
-99.07% -90.56% -616.59% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
275.33% 289.62% 1,075.24% 183.49% 100.00% 135.67% 60.88% 100.00% 100.00% 95.20% 95.67%
Debt to EBITDA
-0.56 -0.45 -0.16 -0.12 0.00 -0.02 -0.02 0.00 0.00 -0.04 -0.03
Net Debt to EBITDA
-0.56 -0.44 0.04 -0.07 0.00 0.05 0.31 0.00 0.00 0.92 0.74
Long-Term Debt to EBITDA
-0.32 -0.22 -0.10 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
-0.76 -0.91 -0.43 -0.31 0.00 -0.05 -0.03 0.00 0.00 -0.06 -0.04
Net Debt to NOPAT
-0.76 -0.90 0.10 -0.19 0.00 0.10 0.40 0.00 0.00 1.34 1.08
Long-Term Debt to NOPAT
-0.43 -0.44 -0.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
-80.38 -57.53 -27.55 -57.06 -43.50 -45.27 -26.82 -24.08 -10.94 -13.40 -17.24
Noncontrolling Interest Sharing Ratio
130.22% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.18 0.18 0.68 0.24 0.54 0.55 0.96 1.52 3.66 3.63 2.73
Quick Ratio
0.01 0.01 0.52 0.12 0.32 0.28 0.77 1.29 3.44 3.26 2.41
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-5.42 -9.07 -0.31 -1.65 -4.83 -4.87 -3.74 -3.21 -4.34 -4.50 -5.19
Operating Cash Flow to CapEx
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
-1.05 -45.58 -2.17 -20.15 -17.77 0.00 -340.22 -356.47 0.00 -409.24 -864.68
Operating Cash Flow to Interest Expense
-0.26 -22.54 -24.39 -34.44 -18.39 0.00 -241.27 -334.11 0.00 -372.18 -460.17
Operating Cash Flow Less CapEx to Interest Expense
-0.26 -22.54 -24.39 -34.44 -18.39 0.00 -241.27 -334.11 0.00 -372.18 -460.17
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.00 0.02 0.03 0.06 0.13 0.09 0.13 0.15
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 6.10 7.07 9.94
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.96
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.03 0.05
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 59.87 51.61 36.73
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 186.19
Days Payable Outstanding (DPO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 49,173.61 25,394.21 13,752.92 7,587.58
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 -49,173.61 -25,334.34 -13,701.31 -7,364.66
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-5.85 -4.97 -5.44 -4.94 -4.13 -3.43 -4.37 -2.96 -2.30 -1.04 -1.70
Invested Capital Turnover
0.00 0.00 0.00 0.00 -0.01 -0.03 -0.09 -0.19 -0.27 -0.55 -0.47
Increase / (Decrease) in Invested Capital
3.36 7.01 -2.45 -1.62 1.72 1.54 1.07 1.98 1.84 2.39 2.67
Enterprise Value (EV)
15 25 26 25 16 7.41 9.54 -1.81 2.15 -2.80 5.84
Market Capitalization
4.90 16 27 23 18 8.66 14 4.50 16 8.65 15
Book Value per Share
($0.86) ($0.38) ($0.12) ($0.09) ($0.49) ($0.49) $0.06 $0.32 $0.41 $0.29 $1.83
Tangible Book Value per Share
($0.86) ($0.38) ($0.12) ($0.09) ($0.49) ($0.49) $0.06 $0.32 $0.41 $0.29 $1.83
Total Capital
-5.78 -4.79 -0.42 -3.76 -2.05 -1.61 0.93 3.34 11 11 7.65
Total Debt
10 9.08 4.06 3.14 0.00 0.57 0.36 0.00 0.00 0.53 0.33
Total Long-Term Debt
5.72 4.34 2.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
10 8.91 -0.96 1.96 -2.08 -1.25 -4.93 -6.30 -14 -11 -9.02
Capital Expenditures (CapEx)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.85 -6.17 -6.64 -5.56 -5.10 -4.32 -5.18 -3.70 -2.96 -1.62 -2.20
Debt-free Net Working Capital (DFNWC)
-5.78 -5.99 -1.62 -4.38 -3.02 -2.50 0.12 2.61 11 10 7.15
Net Working Capital (NWC)
-10 -11 -3.11 -7.52 -3.02 -3.08 -0.25 2.61 11 9.84 6.82
Net Nonoperating Expense (NNE)
5.17 7.40 9.93 -0.03 1.36 1.08 1.10 0.77 0.97 0.79 1.00
Net Nonoperating Obligations (NNO)
10 8.91 -0.96 1.96 -2.08 -1.25 -4.93 -6.30 -14 -11 -9.02
Total Depreciation and Amortization (D&A)
0.01 0.01 0.03 0.03 0.05 0.00 0.01 0.01 0.00 0.00 0.01
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -7,505.88% -3,200.00% -1,210.51% -482.64% -335.41% -131.04% -153.27%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -4,444.12% -1,852.59% 26.87% 340.08% 1,226.79% 839.79% 497.70%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 0.00% -4,444.12% -2,277.78% -57.94% 340.08% 1,226.79% 797.24% 474.65%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($9.25) ($272.75) ($4.75) ($1.03) ($1.10) ($118.00) ($4.40) ($0.18) ($0.13) ($14.00) ($0.90)
Adjusted Weighted Average Basic Shares Outstanding
801.94K 34.67K 2.68M 3.15M 4.09M 37.44K 861.79K 11.33M 26.39M 207.31K 3.92M
Adjusted Diluted Earnings per Share
($9.25) ($272.75) ($4.75) ($1.03) ($1.10) ($118.00) ($4.40) ($0.18) $0.00 ($14.00) $0.00
Adjusted Weighted Average Diluted Shares Outstanding
801.94K 34.67K 2.68M 3.15M 4.09M 872.10K 861.79K 11.33M 36.05M 399.37K 4.00M
Adjusted Basic & Diluted Earnings per Share
$0.00 ($272.75) $0.00 $0.00 $0.00 ($118.00) $0.00 $0.00 $0.00 ($14.00) $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.48M 0.00 3.02M 4.17M 4.46M 872.10K 1.06M 27.91M 36.05M 399.37K 4.00M
Normalized Net Operating Profit after Tax (NOPAT)
-2.06 -2.06 -2.77 -3.27 -3.12 -3.34 -2.68 -1.23 -2.51 -2.11 -2.52
Normalized NOPAT Margin
0.00% 0.00% 0.00% 0.00% -4,587.06% -4,980.45% -913.11% -363.67% -1,369.02% -503.00% -509.52%
Pre Tax Income Margin
0.00% 0.00% 0.00% 0.00% -6,585.29% -6,595.52% -1,286.35% -592.31% -1,897.27% -691.43% -710.71%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
-0.40 -46.55 -87.79 -38.73 -15.68 0.00 -346.00 -226.44 0.00 -274.36 -600.50
NOPAT to Interest Expense
-0.40 -10.33 -19.34 -39.86 -11.47 0.00 -243.22 -136.58 0.00 -192.05 -420.35
EBIT Less CapEx to Interest Expense
-0.40 -46.55 -87.79 -38.73 -15.68 0.00 -346.00 -226.44 0.00 -274.36 -600.50
NOPAT Less CapEx to Interest Expense
-0.40 -10.33 -19.34 -39.86 -11.47 0.00 -243.22 -136.58 0.00 -192.05 -420.35
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

SeaStar Medical (NASDAQ: ICU) continues to look like a development-stage biotech that is growing revenue, but still burning significant cash. Over the last several quarters, the company has posted a steady stream of operating losses, and while revenue has improved meaningfully from 2024 to early 2026, expenses remain far higher than sales. The balance sheet has also improved versus prior periods thanks largely to equity financing, giving the company a much larger cash cushion than it had a year ago.

  • Quarterly revenue has increased from $293,000 in Q1 2025 to $495,000 in Q1 2026, showing early commercial traction.
  • Cash and equivalents rose to $9.35 million at the end of Q1 2026, up from $5.30 million a year earlier.
  • The company ended Q1 2026 with $11.26 million in total assets and $7.32 million in common equity, a clear improvement from the weaker equity position seen in 2024.
  • Operating cash outflow improved sharply year over year in Q1 2026, with cash from operations at negative $2.76 million versus negative $3.49 million in Q1 2025.
  • Debt appears manageable in the latest quarter, with short-term debt down to $331,000 from $363,000 in Q1 2025 and no long-term debt shown.
  • Gross profit remains positive, and Q1 2026 gross profit of $449,000 was higher than the $408,000 reported in Q4 2025.
  • Interest and investment income provided some offset to losses, contributing $91,000 in Q1 2026.
  • Operating losses remain large, with Q1 2026 operating loss at $3.60 million versus revenue of only $495,000.
  • Net loss widened to $3.52 million in Q1 2026, compared with $2.00 million in Q2 2025 and $2.90 million in Q4 2025.
  • The company is still heavily dependent on external funding, as financing cash inflows were needed to offset ongoing operating outflows in every recent quarter.

Longer-term trend: SeaStar Medical’s revenue trend is improving, but not fast enough yet to cover its cost structure. Quarterly revenue moved from essentially zero in early 2024 to the low hundreds of thousands by 2025 and now nearly half a million in Q1 2026. At the same time, operating expenses have stayed in the multi-million-dollar range, driven by R&D and SG&A. That means the business is still well short of breakeven.

Bottom line: ICU has made progress on revenue and liquidity, but it remains a high-risk, cash-burning biotech. Investors will likely want to see sustained revenue growth, tighter spending, and a clear path to reducing operating losses before the story looks fundamentally healthier.

07/19/26 07:57 AM ETAI Generated. May Contain Errors.

LMF Acquisition Opportunities Financials - Frequently Asked Questions

According to the most recent income statement we have on file, LMF Acquisition Opportunities' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

LMF Acquisition Opportunities' net income appears to be on an upward trend, with a most recent value of -$12.15 million in 2025, rising from -$4.60 million in 2021. The previous period was -$24.83 million in 2024.

LMF Acquisition Opportunities' total operating income in 2025 was -$12.18 million, based on the following breakdown:
  • Total Gross Profit: $1.18 million
  • Total Operating Expenses: $13.36 million

Over the last 4 years, LMF Acquisition Opportunities' total revenue changed from $0.00 in 2021 to $1.23 million in 2025, a change of 123,400,000.0%.

LMF Acquisition Opportunities' total liabilities were at $3.74 million at the end of 2025, a 45.3% decrease from 2024, and a 1,400.1% increase since 2020.

In the past 5 years, LMF Acquisition Opportunities' cash and equivalents has ranged from $38.39 thousand in 2020 to $11.98 million in 2025, and is currently $11.98 million as of their latest financial filing in 2025.

Over the last 4 years, LMF Acquisition Opportunities' book value per share changed from -0.22 in 2021 to 0.29 in 2025, a change of -233.9%.



Financial statements for NASDAQ:LMAOW last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners